Understanding Patient Preference on Colorectal Cancer Screening Options-PSU

Completed

Conditions studied: Colo-rectal Cancer

In brief

There are significant barriers to colorectal cancer screening within underserved populations due to the cost, accessibility, and acceptability of screening methods. Patient-friendly approaches that minimize stress and discomfort for the patient are needed to enhance screening compliance and achieve an early diagnosis. The primary aim of this study is to examine whether the availability of a blood-based screening option, which can be done at the point of service and is familiar to patients, will improve patient compliance to recommended CRC screening

Key facts

Study ID

NCT06444542

Run by

Milton S. Hershey Medical Center

People needed

297

Starts

2024-09-16

Expected to finish

2025-12-18

Last updated by the study team

2026-02-20

Who can join

Age: 45 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be enrolled in this study, participants must meet all the following criteria:
• Between 45-75 years of age
• Language Proficiency: participants must be fluent in English or Spanish
• Have an average risk for colorectal cancer
• Be a patient at one of our partner FQHCs
• Received a screening order (either using a stool-based test or colonoscopy) six months ago and failed or refused to complete the screening test
• Able and willing to provide a blood sample per protocol

You may not qualify if…

• Participants will be excluded from enrolling in the study if they meet any of the following:
• Family history
• One first-degree relative diagnosed with CRC or advanced adenoma at age <60 years
• Two first-degree relatives diagnosed with CRC or advanced adenoma at any age
• Known hereditary gastrointestinal cancer syndromes, such as Lynch Syndrome or Familial Adenomatous and Polyposis (FAP)
• Personal History
• Participants who do not speak either Spanish or English
• History of CRC or adenoma
• History of cancers
• History of inflammatory bowel disease, including chronic ulcerative colitis and Crohn's disease
• Have a recorded up to date CRC screening
• Blood product transfusion in the past 120 days
• A medical condition which, in the opinion of the patient's health provider, should preclude enrollment in the study

Where it is running

• Penn State College of Medicine — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.